- HK$3.91bn
- HK$25.23bn
- CNY6.69bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5,800 | 3,325 | 3,494 | 5,202 | 6,686 |
Cost of Revenue | |||||
Gross Profit | 2,766 | 1,556 | 1,778 | 2,888 | 3,247 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5,750 | 4,806 | 3,392 | 4,801 | 5,997 |
Operating Profit | 49.8 | -1,481 | 102 | 400 | 689 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 76 | -1,498 | 83.6 | 405 | 709 |
Provision for Income Taxes | |||||
Net Income After Taxes | 30.9 | -1,156 | 29 | 371 | 555 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 30.9 | -1,156 | 29 | 371 | 555 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 30.9 | -1,156 | 29 | 371 | 555 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.004 | -0.183 | 0.014 | 0.056 | 0.083 |
Dividends per Share | |||||
Special Dividends per Share |